Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Trastuzumab

5

XII.f Cardiomyopathy (acute, subacute, chronic)

2
Last update : 22/08/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Trastuzumab deruxtecan
4
Trastuzumab emtansine (Ado-trastuzumab emtansine - TDM-1)
1

Publications

A novel way to manage trastuzumab cardiotoxicity.
Cancer chemotherapy and pharmacology 2018 Apr;81;791-796 2018 Apr
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report.
BMC cancer 2017 Nov 07;17;722 2017 Nov 07
Acute cardiotoxic effects of adjuvant trastuzumab treatment.
Angiology 2014 Nov;65;950 2014 Nov
Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution's experience.
Journal of the Saudi Heart Association 2010 Jul;22;133-6 2010 Jul
Trastuzumab (Herceptin)-associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review.
The American journal of emergency medicine 2009 Sep;27;903.e1-3 2009 Sep
Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study.
Journal of cardiac failure 2009 Oct;15;651-7 2009 Oct

Powered by

  • ^
  • Contact
  • Cookies
  • About